Weather , , 0°C

Cushing’s Syndrome Market Analysis, Market Size, Trends, Epidemiology, Leading Companies And Therapies | Delveinsight

 Breaking News
  • No posts were found

Cushing’s Syndrome Market Analysis, Market Size, Trends, Epidemiology, Leading Companies And Therapies | Delveinsight

May 12
22:34 2021
Cushing’s Syndrome Market Analysis, Market Size, Trends, Epidemiology, Leading Companies And Therapies | Delveinsight

DelveInsight Business Research LLP
DelveInsight’s “Cushing’s Syndrome – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Cushing’s Syndrome, historical and forecasted epidemiology as well as the Cushing’s Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on “Cushing’s Syndrome (CS) – Market Insights, Epidemiology, and Market Forecast-2030

DelveInsight’s “Cushing’s Syndrome (CS) – Market Insights, Epidemiology, and Market Forecast-2030″ report delivers an in-depth understanding of the  Cushing’s Syndrome (CS), historical and forecasted epidemiology as well as the  Cushing’s Syndrome (CS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Report:

  1. According to the Orphanet, the prevalence of endogenous Cushing’s Syndrome (CS) is 1/26,000 and, in the EU, it has an annual prevalence of 1/1,400,000-1/400,000, with a peak prevalence at 25-40 years of age.

  2. As per the research, although it may occur in children, Cushing’s syndrome most commonly affects adults between the ages of 25 to 40.

  3. As per a study, the prevalence of Cushing’s disease maybe 5 to 25 per million per year. However, the reported prevalence was much lower (1.2 to 2.4 per million per year) in one population-based study. In a United States study, the prevalence was higher than previously reported in European studies as it was found to affect 6.2 to 7.6 per million person-years.

Key benefits of the report:

1. Cushing’s Syndrome (CS) market report covers a descriptive overview and comprehensive insight of the Cushing’s Syndrome (CS) epidemiology and Cushing’s Syndrome (CS) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2. Cushing’s Syndrome (CS) market report provides insights on the current and emerging therapies.

3. Cushing’s Syndrome (CS) market report provides a global historical and forecasted market covering drug outreach in 7MM.

4. The Cushing’s Syndrome (CS) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the  Cushing’s Syndrome (CS) market.

Request for sample pages: https://www.delveinsight.com/sample-request/cushings-syndrome-market

Cushing’s Syndrome (CS): Overview

Cushing’s syndrome (CS) is a rare problem caused when the adrenal gland(s) makes too much of a hormone called cortisol. CS is most often due to a tumor or mass found in the pituitary gland, but can also be caused by tumors in the adrenal glands themselves.

People with Cushing’s syndrome may see their face get round (“moon face”), they gain weight in unusual ways, bruise easily or feel weak, tired and sad. Women and men may also notice fertility and other problems. CS is most often found in adults between the ages of 20 and 50.

The key player involved in Cushing’s Syndrome (CS) market:

  1. Recordati, 

  2. Corcept Therapeutics, 

  3. Millendo Therapeutics, 

  4. Cortendo, 

  5. SteroTherapeutics

The launch of the emerging therapies is expected to significantly impact the  Cushing’s Syndrome (CS) treatment scenario in the upcoming years:-

Drug covered

  1. Osilodrostat 

  2. Relacorilant 

  3. ATR-101 

  4. Levoketoconazole 

  5. ST-002 

Request a free sample report @https://www.delveinsight.com/sample-request/cushings-syndrome-market

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Cushing’s Syndrome (CS) Patient Share (%) Overview at a Glance

5. Cushing’s Syndrome (CS) Market Overview at a Glance

6. Cushing’s Syndrome (CS) Disease Background and Overview

7. Cushing’s Syndrome (CS) Epidemiology and Patient Population

8. Country-Specific Patient Population of  Cushing’s Syndrome (CS)

9. Cushing’s Syndrome (CS) Current Treatment and Medical Practices

10. Unmet Needs

11. Cushing’s Syndrome (CS) Emerging Therapies

12. Cushing’s Syndrome (CS) Market Outlook

13. Country-Wise Cushing’s Syndrome (CS) Market Analysis (2017–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Cushing’s Syndrome (CS) Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Related Reports:

Cushing’s Syndrome (CS)- Pipeline Insights, 2021

“Cushing’s Syndrome (CS) Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenario and growth prospects across the  Cushing’s Syndrome (CS) market. A detailed picture of the  Cushing’s Syndrome (CS) pipeline landscape is provided, which includes the disease overview and  Cushing’s Syndrome (CS) treatment guidelines.

Cushing’s Syndrome (CS) – Epidemiology Forecast to 2030

DelveInsight’s ‘Cushing’s Syndrome (CS) – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Cushing’s Syndrome (CS) epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Related Articles

Calendar

June 2021
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  

Categories